Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe location entry changes from Padua, Italy, 35128 to Padova, Italy, 35128. It's a localization adjustment of a single site name.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded revision labeled v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision label updated to v3.4.3; the previous label v3.4.2 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded metadata updates including a new 'Gastric cancer' tag and a reference to the Genetic and Rare Diseases Information Center, plus a new revision (v3.4.2). No substantive changes to study design, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing Revision: v3.4.0. This represents a small UI/version update with no impact on study content, eligibility criteria, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page adds new metadata/UI items: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, while removing older labels: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.